Fresh-frozen plasma use in a South African tertiary hospital by Visser, Adele et al.
RESEARCH
366  June 2012, Vol. 102, No. 6  SAMJ
Transfusion of blood and blood products is a potentially life-saving 
measure, but is not without risk.1 Fresh-frozen plasma (FFP) is produced 
from a single whole-blood donor unit, or through plasmapheresis.2 
Despite the lack of cellular components in FFP, complications may 
follow transfusion. These include allergic reactions, transfusion-related 
acute lung injury (TRALI), haemolysis, fluid overload and infectious 
complications.3 Therefore, FFP transfusion should be restricted to 
cases where its clinical benefit has been established.1
Despite available guidelines on appropriate indications,2 there is 
increasing worldwide use of FFP transfusion4 with inappropriate 
indications,5 particularly in tertiary healthcare settings.4 We evaluated the 
utilisation of FFP and the prescription practices of attending clinicians in 
a South African tertiary hospital.
Materials and methods
All patients who received FFP transfusions from February to April 
2010 at the Steve Biko Academic Hospital were included. All units 
were exclusively requested by doctors, and indications of transfusion 
and completeness of requisition forms were evaluated.
Appropriate indications were based on Guidelines of the South African 
National Blood Transfusion Service (SANBS). Absolute indications are: 
replacement of single-factor deficiencies when factor concentrate was 
not available, immediate reversal of warfarin effect, vitamin K deficiency 
associated bleeding, acute disseminated intravascular coagulation (DIC), 
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Fig. 1. Breakdown of indications stated on request forms for requisition and 
transfusion of FFP: a – cases where transfusions were deemed appropriate, 
and b – cases where transfusions did not comply with SANBS guidelines.
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thrombotic thrombocytopenic purpura (TTP), inherited deficiencies 
in coagulation, and suxamethonium chloride apnoea. Conditional uses 
include liver disease, cardiopulmonary bypass surgery, and as part of a 
massive transfusion.
Results
In total, 416 requests were submitted for FFP, amounting to 1 020 
units transfused in 312 patients. Internal Medicine, General Surgery, 
Surgical ICU, and Obstetrics and Gynaecology were the departments 
that used the most FFP units. Of units transfused, 289 (39.5%) were 
considered inappropriate. Of the more than 60% of appropriately 
transfused units, disseminated intravascular haemolysis and massive 
transfusions accounted for more than 60%. Vitamin K deficiency 
(with or without warfarin effect) in the presence of active bleeding 
accounted for 20% of cases (Fig. 1). Most of the inappropriate 
transfusions were classified as the patient’s final diagnosis stated 
on the request form, which had no bearing on the indication for 
transfusion. Despite evaluating the patients’ laboratory records, the 
reasons warranting transfusion with FFP could not be determined. 
In more than 25% of cases, patients had features of bleeding, but 
FFP was administered without red-cell concentrate, and they did not 
fit the criteria for a massive transfusion. In the remainder, patients 
were either at risk of bleeding with no active bleeding at the time 
of ordering FFP and no subsequent laboratory features of bleeding 
(decrease in haemoglobin concentration or haematocrit), or no 
indication or diagnosis was supplied. Of note, most of the bleeding 
risks were due to platelet dysfunction (renal failure or idiopathic 
ITP), and administration of FFP would have had minimal impact. 
Most of these inappropriate cases were from the Departments of 
Obstetrics and Gynaecology and Internal Medicine. Of all request 
forms submitted, only 22% contained sufficient information for the 
blood transfusion services of the indication for transfusion.
Discussion
FFP is a frequently used blood-derived product, and worldwide 
inappropriate use has been noted.4 This has a significant impact 
on medical costs and patient morbidity and mortality.1 To 
identify areas for improved patient care and reduced resource 
expenditure, it is essential to determine local utilisation practices 
and adherence to guidelines. The auditing process is valuable 
in determining areas requiring improvement, and its use in 
transfusion medicine has been advocated.6 Evaluation of the 
requisition forms is a valuable indicator of appropriateness of FFP 
ordering.3 Therefore, we used both these parameters in our study 
to evaluate local utilisation practices of FFP.
Inappropriate FFP use should prompt interventions including the 
use of local guidelines in hospital training,3 continuing professional 
development programmes,3 discussing patients receiving blood or blood 
products on daily ward rounds,6 and the use of computerised monitoring 
programmes. Although these have been implemented with varying 
degrees of success, intervention is needed when considering global trends 
in FFP use.
In conclusion, transfusion with FFP is a medical intervention that 
carries a risk and should be undertaken with due care. Although this 
study was done in one centre, it is evident that clinicians lack knowledge 
of appropriate indications for the administration of FFP. Intervention is 
necessary to improve patient outcomes and reduce expenditure.
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